Kanglemycin C vs ciclosporin on immunosuppression in mice

Acta Pharmacologica Sinica

Volumn 20, Issue 1, 1999, Pages 65-68

  Li, Jian Ming ^a   Lin, Zhi Bin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cyclosporine; Delayed hypersensitivity; Hemolysin; Homologous transplantation; Immunosuppression; Kanglemycin C; Phagocytosis

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; BENZ[A]ANTHRACENE; CYCLOSPORIN; HEMOLYSIN; KANGLEMYCIN C; NEUTRAL RED; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; SKIN ALLOGRAFT;

ANIMALS; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HEMOLYSIN PROTEINS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHAGOCYTOSIS; RIFAMYCINS; SKIN TRANSPLANTATION; TRANSPLANTATION, HETEROTOPIC;

EID: 0032893798     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wang NJ, Yang XS, He CH. The structural elucidation of kanglemycin C. Chin J Antibiot 1994; 19: 86-90.
2. Han BL, Zhou JQ, Sun CH, Wang NJ, Kyuichi N. A novel immunosuppressant, kanglemycin C, its fermentation, isolation, physico-chemical and biological properties. Chin J Antibiot 1995; 20: 273-7.
3. Borel JF. Pharmacology of cyclosporin. IV. Pharmacological properties in vivo. Pharmacol Rev 1989; 41: 259-371.
4. Burckhardt JJ, Guggenheim. Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function. Immunology 1979; 36: 753-7.
5. Markowka L, Sher LS, Cramer DV. The development of brequinar as an immunosuppressive drug for transplantation. Immunol Rev 1993; 136: 51-70.
6. Ivan RI. Essential immunology. 8th ed. Oxford: Blackwell Scientific Publications; 1994. p 312-36.
7. Gill HK, Liew FY. Regulation of delayed hypersensitivity reaction. III. Effect of cyclophosphamide on the suppresser cells for delayed hypersensitivity reaction to sheep erythrothyte in mice. Eur J Immunol 1978; 8: 172-6.
8. Ivan RI. Essential immunology. 8th ed. Oxford: Blackwell Scientific Publications; 1994. p 337-62.
9. Chen MI, Wei W, Zhang H, Liang JS. The experimental methods of immunosuppressive agents and immunostimulants. In: Xu SY, Bian RL, Chen X, editors. The experimental methodology of pharmacology. 2nd ed. Beijing: People's Medical Publishing House; 1994. p 1208-45.
10. Mayami H, Good RA. Depending of cyclophosphamide-induced skin allograft tolerance on age of adult recipient mice. Transplant 1988; 46: 451-5.
11. Shi MM, Ma BL, Yu H. Approaching the heart/ heart muscle allograft model in the dorsum of mouse ear. Shanghai J Immunol 1981; 1: 41-5.
12. Wang XJ, Ding GF, Fan SG. The effects of different opiate peptides and ACTH on the phagocytosis of mouse macrophages. Chin J Immunol 1987; 3: 211-3.